T reatment of moderate-to-severe Crohn's disease should prioritize early use of higher-efficacy advanced therapies rather ...

The American Gastroenterological Association (AGA) has released a comprehensively updated clinical guideline on the ...

The (AGA) has released a comprehensively updated clinical guideline on the pharmacological management of moderate-to-severe Crohn's disease.

The American Gastroenterological Association has released updated guidelines for treating moderate-to-severe Crohn’s disease, outlining 16 evidence-based recommendations that prioritize advanced ...

Find out about the early symptoms of Crohn’s disease, to detect it sooner and manage it better. Learn to pay attention to ...

Ultraprocessed foods are also often high in added sugars (which have been linked to greater risks of colorectal cancer and ...

SetPoint Medical, a commercial-stage medical technology company dedicated to improving care for people living with chronic ...

Technology has been rapidly advancing, with digital apps showing promise in IBD management. But are they evidence based? And ...

A new flu variant, called subclade K, is spreading overseas and may set the stage for another tough winter in the United ...

Tyruko (natalizumab-sztn), a biosimilar to Tysabri (natalizumab), has been made available by Sandoz, according to developer Polpharma Biologics.